LAM RESEARCH CORPORATION (LRCX) FY2024 YTD Q3 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2023-06-26 to 2024-03-31

Swipe to see the full flow
LAM RESEARCH CORPORATION cash flow reconciliation, Jun 26, 2023 through Mar 31, 2024One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $2,807,490,000.00Changes in operating assets and liabilities → Operating adjustments reconciliation: $620,405,000.00Depreciation and amortization → Operating adjustments reconciliation: $271,342,000.00Equity-based compensation expense → Operating adjustments reconciliation: $213,966,000.00Other, net → Operating adjustments reconciliation: $14,242,000.00Operating adjustments reconciliation → Net cash from operating activities: $982,349,000.00Operating adjustments reconciliation → Deferred income taxes: $137,606,000.00Proceeds from maturities of available-for-sales securities → investing reconciliation: $34,336,000.00Proceeds from sales of available-for-sale securities → investing reconciliation: $3,430,000.00investing reconciliation → Capital expenditures and intangible assets: $295,922,000.00investing reconciliation → Other, net: $10,845,000.00Net cash used in financing activities → financing reconciliation: $3,421,699,000.00Reissuance of treasury stock related to employee stock purchase plan → financing reconciliation: $53,081,000.00Proceeds from issuance of common stock → financing reconciliation: $12,757,000.00financing reconciliation → Treasury stock purchases: $2,469,257,000.00financing reconciliation → Dividends paid: $757,453,000.00financing reconciliation → Principal payments on debt, including finance lease obligations: $255,155,000.00financing reconciliation → Other, net: $5,672,000.00Net cash used in investing activities → investing reconciliation: $269,001,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $5,587,372,000.00Net cash from operating activities → Cash sources and uses: $3,789,839,000.00Cash sources and uses → Exchange-rate effect: $12,758,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $5,673,753,000.00Cash sources and uses → Net cash used in investing activities: $269,001,000.00Cash sources and uses → Net cash used in financing activities: $3,421,699,000.00Net income: $2,807,490,000.00Net income+$2.81 BDepreciation and amortization: $271,342,000.00Depreciation & amortization+$271.34 MDeferred income taxes: -$137,606,000.00Deferred income taxes−$137.61 MEquity-based compensation expense: $213,966,000.00Stock-based compensation+$213.97 MChanges in operating assets and liabilities: $620,405,000.00Operating capital changes+$620.41 MOther, net: $14,242,000.00Other non-cash items+$14.24 MNet cash from operating activities: $3,789,839,000.00Operating cash+$3.79 BOperating adjustments reconciliation: $1,119,955,000.00Principal payments on debt, including finance lease obligations: -$255,155,000.00Debt & lease obligations repaid−$255.16 MProceeds from issuance of common stock: $12,757,000.00Common stock issued+$12.76 MOther, net: -$5,672,000.00Other financing, net−$5.67 MDividends paid: -$757,453,000.00Dividends paid−$757.45 MTreasury stock purchases: -$2,469,257,000.00Common stock repurchases−$2.47 BReissuance of treasury stock related to employee stock purchase plan: $53,081,000.00Treasury stock sold+$53.08 MNet cash used in financing activities: -$3,421,699,000.00. Cash required to fund net payments.Financing cash−$3.42 Bfinancing reconciliation: $3,487,537,000.00Capital expenditures and intangible assets: -$295,922,000.00Capital expenditures−$295.92 MProceeds from maturities of available-for-sales securities: $34,336,000.00AFS securities maturities+$34.34 MOther, net: -$10,845,000.00Other investing, net−$10.85 MBusiness acquisitions, net of cash acquired: $0.00Proceeds from sales of available-for-sale securities: $3,430,000.00AFS securities sales+$3.43 MNet cash used in investing activities: -$269,001,000.00. Cash required to fund net payments.Investing cash−$269.00 Minvesting reconciliation: $306,767,000.00Cash sources and uses: $9,377,211,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $5,587,372,000.00Beginning cash$5.59 BEnding cash: Cash, cash equivalents, and restricted cash: $5,673,753,000.00Ending cash$5.67 BExchange-rate effect: -$12,758,000.00FX effect−$12.76 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$3.49 BOperating cash − cash spent on productive assetsCash flow / Net income1.35×Operating cash flow ÷ net incomeNet cash change+$86.38 MEnding cash − beginning cash
Chart details

LAM RESEARCH CORPORATION cash flow reconciliation, Jun 26, 2023 through Mar 31, 2024

Cash flows for Jun 26, 2023 through Mar 31, 2024. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Jun 25, 2023. Ending cash: Mar 31, 2024. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Jun 25, 2023
5,587,372,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
3,789,839,000 US dollars. Net cash provided.
Net income
2,807,490,000 US dollars
Depreciation and amortization
271,342,000 US dollars
Deferred income taxes
negative 137,606,000 US dollars
Equity-based compensation expense
213,966,000 US dollars
Changes in operating assets and liabilities
620,405,000 US dollars
Other, net
14,242,000 US dollars
Investing activities
negative 269,001,000 US dollars. Net cash used.
Capital expenditures and intangible assets
negative 295,922,000 US dollars
Proceeds from maturities of available-for-sales securities
34,336,000 US dollars
Other, net
negative 10,845,000 US dollars
Business acquisitions, net of cash acquired
0 US dollars
Proceeds from sales of available-for-sale securities
3,430,000 US dollars
Financing activities
negative 3,421,699,000 US dollars. Net cash used.
Principal payments on debt, including finance lease obligations
negative 255,155,000 US dollars
Proceeds from issuance of common stock
12,757,000 US dollars
Other, net
negative 5,672,000 US dollars
Dividends paid
negative 757,453,000 US dollars
Treasury stock purchases
negative 2,469,257,000 US dollars
Reissuance of treasury stock related to employee stock purchase plan
53,081,000 US dollars
Operating adjustment reconciliation
1,119,955,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
3,487,537,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
306,767,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
negative 12,758,000 US dollars
Ending cash on Mar 31, 2024
5,673,753,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
9,377,211,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
86,381,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
1.35×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
3,789,839,000 US dollars. Operating cash flow used in the free cash flow calculation.
cash spent on productive assets
295,922,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
3,493,917,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $982.35M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash spent on productive assets equals free cash flow: 3,789,839,000 US dollars minus 295,922,000 US dollars equals 3,493,917,000 US dollars.
LAM RESEARCH CORPORATION (LRCX) FY2024 YTD Q3 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!